Benzinga | Aug 10, 2020 08:21AM EDT

Avadel Pharmaceuticals Q2 EPS $0.49 Beats $(0.10) Estimate

Avadel Pharmaceuticals (NASDAQ:AVDL) reported quarterly earnings of $0.49 per share which beat the analyst consensus estimate of $(0.10) by 590 percent. This is a 313.04 percent increase over losses of $(0.23) per share from the same period last year.